Fabrication of solid lipid nanoparticles-based patches of paroxetine and their ex-vivo permeation behaviour

References

• Rehman M, Asadullah Madni AI, Khan WS, et al. Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior. Int J Nanomed. 2015;10:2805.
   PubMed Web of Science ®Google Scholar
• Abousamra MM, Mohsen MA. Solid lipid nanoparticles and nanostructureed lipid carriers of tolnaftate: design, optimization and in-vitro evaluation measurement. Int J Pharm Pharm Sci. 2016;10:100.
   Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47(1):139–151.
   PubMed Web of Science ®Google Scholar
• Paroxetine Medscape. 2022. Available from: https://reference.medscape.com/drug/paxil-brisdelle-paroxetine-342959
   Google Scholar
• Shah R, Eldridge D, Palombo E, et al. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 2014;25(1):59–75.
   Google Scholar
• Vijayanand P, Jyothi V, Aditya N, et al. A. Development and characterization of solid lipid nanoparticles containing herbal extract: in vivo antidepressant activity. J Drug Delivery. 2018;2018:1–7.
   Web of Science ®Google Scholar
• El-Nabarawi MA, Bendas ER, El Rehem RTA, et al. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm. 2013;443(1-2):307–317.
   PubMed Web of Science ®Google Scholar
• Prajapati P, Oza M, Shah HM, et al. Formulation and evaluation of sublingual tablet of paroxetine Hcl. Int J Pharma Bio Sci. 2014;3(2):1019–1036.
   Google Scholar
• Patel K, Padhye S, Nagarsenker M. Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design. AAPS PharmSciTech. 2012;13(1):125–133.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur R. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349.
   PubMed Web of Science ®Google Scholar
• Suresh G, Manjunath K, Venkateswarlu V, et al. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles. AAPS Pharmscitech. 2007;8(1):E162–E170.
   Web of Science ®Google Scholar
• Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull. 2015;5(3):305–313.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm. 2004;58(2):279–289.
   PubMed Web of Science ®Google Scholar
• Kurz A, Farlow M, Lefevre G. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review. Int J Clin Pract. 2009;63(5):799–805.
   PubMed Web of Science ®Google Scholar
• Wokovich AM, Prodduturi S, Doub WH, et al. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm. 2006;64(1):1–8.
   PubMed Web of Science ®Google Scholar
• Bhalekar MR. Solid lipid nanoparticles incorporated transdermal patch for improving the permeation of piroxicam. Asian J Pharm. 2016;10(1):45–51.
   Google Scholar
• Ekambaram P, Sathali AAH. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011;3(3):216–220.
   PubMedGoogle Scholar
• Onal A, Kepekçi SE, Oztunç A. Spectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tablets. J AOAC Int. 2005;88(2):490–495.
   PubMed Web of Science ®Google Scholar
• Abdellatif AA, El-Telbany DFA, Zayed G, et al. Hydrogel containing PEG-Coated fluconazole nanoparticles with enhanced solubility and antifungal activity. J Pharm Innov. 2018;14:1–11.
   Web of Science ®Google Scholar
• Ding Y, Nielsen KA, Nielsen BP, et al. Lipid-drug-conjugate (LDC) solid lipid nanoparticles (SLN) for the delivery of nicotine to the oral cavity–optimization of nicotine loading efficiency. Eur J Pharm Biopharm. 2018;128:10–17.
   PubMed Web of Science ®Google Scholar
• Mohamed RA, Abass HA, Attia MA, et al. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository. J Pharm Pharmacol. 2013;65(11):1607–1621.
   PubMed Web of Science ®Google Scholar
• Idrees A, Rahman NU, Javaid Z, et al. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose. Acta Pol Pharm. 2014;71(2):287–295.
   PubMed Web of Science ®Google Scholar
• Mutalik S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci. 2004;93(6):1577–1594.
   PubMed Web of Science ®Google Scholar
• Rajabalaya R, Khanam J, Nanda A. Design of a matrix patch formulation for long-acting permeation of diclofenac potassium. Asian J Pharm Sci. 2008;3(1):30–39.
   Google Scholar
• Ayesha N. Development of tizanidine HCl transdermal patches: in-vitro and ex-vivo characterization. J Drug Deliv Therapeut. 2019;9(1-s):295–300.
   Google Scholar
• Lin Y-K, Huang Z-R, Zhuo R-Z, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 2010;5:117.
   PubMed Web of Science ®Google Scholar
• Ubaidulla U, Reddy MV, Ruckmani K, et al. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 2007;8(1):E13–E20.
   PubMed Web of Science ®Google Scholar
• Kurakula M, Ahmed OAA, Fahmy UA, et al. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res. 2016;26(4):288–296.
   PubMed Web of Science ®Google Scholar
• Gannu R, Vishnu V, Kishan Y, et al. Y. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. CDD. 2007;4(1):69–76.
   PubMedGoogle Scholar
• Bagchi A, Dey BK. Formulation, in-vitro evaluations and skin irritation study of losartan potassium transdermal patches. Iran J Pharm Sci. 2010; 6: 163–170.
   Google Scholar
• Draize JH. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–390.
   Web of Science ®Google Scholar
• Villanueva-Martínez A, Hernández-Rizo L, Ganem-Rondero A. Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate. Int J Pharm. 2020;582:119312.
   PubMed Web of Science ®Google Scholar
• Reithmeier H, Herrmann J, Göpferich A. Lipid microparticles as a parenteral controlled release device for peptides. J Control Release. 2001;73(2-3):339–350.
   PubMed Web of Science ®Google Scholar
• Kumar PP, Gayatri P, Sunil R, et al. Atorvastatin loaded solid lipid nanoparticles: formulation, optimization, and in vitro characterization. IOSR J Pharm. 2012;2(5):23–32.
   Google Scholar
• Müller R, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47(1):3–19.
   PubMed Web of Science ®Google Scholar
• Nasiri F, Faghfouri L, Hamidi M. Preparation, optimization and in-vitro characterization of α-Tocopherol-loaded solid lipid nanoparticles (SLNs). Drug Dev Ind Pharm. 2020;1:42-46.
   Web of Science ®Google Scholar
• Asasutjarit R, Lorenzen S-I, Sirivichayakul S, et al. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-Hugag transfection. Pharm Res. 2007;24(6):1098–1107.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Baboota S, Ahuja A, et al. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharmscitech. 2007;8(4):191.
   Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95(3):627–638.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S, Khare P, et al. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 2010;17(6):443–451.
   PubMed Web of Science ®Google Scholar
• Cozar I, Szabó L, Mare D, et al. IR, Raman, SERS and DFT study of paroxetine. J Mol Struct. 2011;993(1-3):243–248.
   Web of Science ®Google Scholar
• Weiseng N, Lee C, Cheng SF, et al. Biocompatible polyurethane scaffolds prepared from glycerol monostearate-derived polyester polyol. J Polym Environ. 2018;26: 2881–2900.
   Web of Science ®Google Scholar
• Fu X, Weibo K, Zhang Y, et al. Novel solid-solid phase change materials with biodegradable trihydroxy surfactant for thermal energy storage. RSC Adv. 2015;5: 68881–68889.
   Web of Science ®Google Scholar
• Bhalekar MR, Pokharkar V, Madgulkar A, et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 2009;10(1):289–296.
   PubMed Web of Science ®Google Scholar
• Baig MS, Ahad A, Aslam M, et al. Application of Box–Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity. Int J Biol Macromol. 2016;85:258–270.
   PubMed Web of Science ®Google Scholar
• Peng L-H, Wei W, Shan Y-H, et al. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo. Drug Dev Ind Pharm. 2017;43(1):55–66.
   PubMed Web of Science ®Google Scholar
• Lan Y, Minnich AJ, Chen G, et al. Enhancement of thermoelectric figure‐of‐merit by a bulk nanostructuring approach. Adv Funct Mater. 2010;20(3):357–376.
   Web of Science ®Google Scholar
• Sugi K, Itaya N, Katsura T, et al. Improved synthesis of paroxetine hydrochloride propan-2-ol solvate through one of metabolites in humans, and characterization of the solvate crystals. Chem Pharm Bull. 2000;48(4):529–536.
   PubMed Web of Science ®Google Scholar
• Joshi SA, Jalalpure SS, Kempwade AA, et al. Fabrication and in-vivo evaluation of lipid nanocarriers based transdermal patch of colchicine. J Drug Delivery Sci Technol. 2017;41:444–453.
   Web of Science ®Google Scholar
• Elnaggar YS, El-Massik MA, Abdallah OY. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomed. 2011;6:3195.
   PubMed Web of Science ®Google Scholar